Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
NuProbe is a biotechnology company dedicated to revolutionizing molecular diagnostics. They develop and commercialize ultrasensitive and multiplexed nucleic acid detection technologies, with a primary focus on oncology, particularly liquid biopsy for cancer screening, diagnosis, and monitoring. Their proprietary Blocker Displacement Amplification (BDA) and Quantitative Amplicon Sequencing (QASeq) technologies enable the detection of rare genetic variants with high accuracy and sensitivity. NuProbe aims to improve patient outcomes by providing innovative tools for early disease detection and personalized medicine. The company has operations in both the USA and China, addressing global healthcare needs.
The Houston headquarters serves as the central node for global corporate strategy, research and development leadership, business development, strategic partnerships, and administrative functions for North American operations.
Located within JLABS @ TMC, part of the Texas Medical Center, offering access to state-of-the-art laboratory facilities, shared equipment, and a vibrant collaborative environment designed to accelerate biotech innovation.
The work culture at NuProbe's Houston HQ is likely dynamic, science-driven, and entrepreneurial, fostering innovation, collaboration among multidisciplinary teams, and a strong focus on translating research into impactful diagnostic solutions.
Houston's Texas Medical Center ecosystem provides NuProbe with unparalleled access to world-class research institutions, clinical collaborators, a skilled talent pool, and venture capital, crucial for a company at the forefront of diagnostic technology development.
NuProbe maintains a significant global presence with key operational hubs in Houston, Texas, USA, and in Shanghai and Suzhou, China. These locations support comprehensive functions including research and development, manufacturing, clinical validation, and commercial activities. This strategic distribution allows NuProbe to tap into diverse talent pools, access leading scientific and medical ecosystems, and cater to the specific needs of both Western and Eastern healthcare markets, driving the global adoption of its innovative molecular diagnostic technologies.
2450 Holcombe Blvd, Suite X
Houston
Texas
USA
Address: Building 7, Lane 1188, Tianxiong Road, Minhang District, Shanghai, China
To leverage local scientific talent, address the specific healthcare needs of the region, facilitate local regulatory processes, and drive commercialization efforts in the rapidly growing Asian molecular diagnostics market.
Address: BioBay, Suzhou Industrial Park, Suzhou, Jiangsu, China
To provide scalable, high-quality manufacturing capabilities, ensuring cost-effective production and reliable supply of NuProbe's products to meet increasing global demand, particularly within Asia.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NuProbe' leadership includes:
NuProbe has been backed by several prominent investors over the years, including:
NuProbe strengthened its executive leadership in the past year with a key hire in business development to drive strategic growth. No major executive departures have been publicly announced, indicating stability in the core leadership team.
Discover the tools NuProbe uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
NuProbe likely utilizes standard corporate email address formats. Common patterns for technology and biotech companies include combinations of first name, last name, and initials. For NuProbe, the most probable formats are [first_initial][last]@nuprobe.com or [first].[last]@nuprobe.com. The success rate in guessing these formats for outreach can be moderately high, especially for general inquiries or publicly listed individuals.
NuProbe's common email formats include fLast@nuprobe.com (e.g., jdoe@nuprobe.com) and first.last@nuprobe.com (e.g., jane.doe@nuprobe.com).
Format
lzhou@nuprobe.com
Example
75%
Success rate
Business Wire • March 13, 2024
NuProbe entered a strategic partnership with Agena Bioscience to co-develop and commercialize ultrasensitive cancer assays. The collaboration aims to combine NuProbe's Blocker Displacement Amplification (BDA) technology with Agena's MassARRAY System to enhance liquid biopsy capabilities for oncology applications....more
NuProbe Website News • July 20, 2023
NuProbe announced the publication of its research on a novel quantitative hotspot SNP mutation detection method in the prestigious journal Nature Biomedical Engineering. The study showcased the capabilities of its Blocker Displacement Amplification (BDA) technology for highly sensitive and accurate detection of low-frequency genetic variants....more
NuProbe Website News • April 6, 2023
NuProbe announced it would present significant data at the American Association for Cancer Research (AACR) Annual Meeting 2023. The presentations validated its ultrasensitive liquid biopsy assays for detecting low-frequency cancer mutations, highlighting the technology's potential in early cancer detection and disease monitoring....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NuProbe, are just a search away.